Glutamate has been implicated in a wide range of brain pathologies and is thought to be metabolized via the astrocyte-specific enzyme glutamine synthetase (GS). We show here that oligodendrocytes, the myelinating glia of the central nervous system, also express high levels of GS in caudal regions like the midbrain and the spinal cord. Selective removal of oligodendrocyte GS in mice led to reduced brain glutamate and glutamine levels and impaired glutamatergic synaptic transmission without disrupting myelination. Furthermore, animals lacking oligodendrocyte GS displayed deficits in cocaine-induced locomotor sensitization, a behavior that is dependent on glutamatergic signaling in the midbrain. Thus, oligodendrocytes support glutamatergic transmission through the actions of GS and may represent a therapeutic target for pathological conditions related to brain glutamate dysregulation.
Correspondence wen.xin@ucsf.edu (W.X.), antonello.bonci@nih.gov (A.B.) In Brief Xin et al. show that mature oligodendrocytes, the myelinating cells of the brain, express the glutaminesynthesizing enzyme glutamine synthetase (GS). Oligodendrocytespecific GS deletion does not impair myelination but disrupts neuronal glutamatergic transmission, thus demonstrating a myelin-independent role for oligodendrocytes in supporting glutamate signaling in the brain.
INTRODUCTION
Glutamate is the major excitatory neurotransmitter in the brain. Following synaptic release, glutamate uptake and degradation are tightly regulated to achieve temporal and spatial signaling specificity and prevent cellular excitotoxicity (Kim et al., 2011; Sattler and Rothstein, 2006; Sheldon and Robinson, 2007) . Currently, astrocytes are considered the sole glial cell type that contributes to glutamate uptake and degradation in the CNS (Jayakumar and Norenberg, 2016; Liang et al., 2006; Ortinski et al., 2010; Papageorgiou et al., 2018; Schousboe et al., 2013; Schousboe, 2019; Sun et al., 2017; Tani et al., 2014; Trabelsi et al., 2017; Yuan et al., 2017) , as they express high levels of glutamate transporters and glutamine synthetase (GS), an enzyme that converts glutamate into glutamine. In keeping with this view, GS is frequently used as an astrocyte-specific marker (Armbruster et al., 2016; Habbas et al., 2015; Okuda et al., 2014; Papageorgiou et al., 2018; Theofilas et al., 2017; Tong et al., 2014) . However, GS expression has also been reported in oligodendrocytes (Bernstein et al., 2014; Takasaki et al., 2010) , glial cells known for producing myelin and ensheathing axons in the CNS (Pan and Chan, 2017) . Although these results remain controversial (Anlauf and Derouiche, 2013; Jayakumar and Norenberg, 2016; Sun et al., 2017) , it is of great physiological and clinical importance to identify all potential cellular and molecular components involved in the life cycle of glutamate. GS deletion from the brain results in neonatal death (He et al., 2010) , and mutations in the GS gene produce severe neuropathology in humans (Hä berle et al., 2012; Spodenkiewicz et al., 2016) . Furthermore, glutamate dysregulation has been implicated in numerous pathological states, including epilepsy, stroke, and substance use disorders, as well as several neurodegenerative diseases (Jayakumar and Norenberg, 2016; Kalivas and Duffy, 1998; Reissner et al., 2015; Sheldon and Robinson, 2007; Spencer and Kalivas, 2017; van der Hel et al., 2005; Yuan et al., 2017) . For these reasons, we sought to unequivocally determine whether GS is expressed by oligodendrocytes and, if so, whether oligodendrocyte GS plays a role in maintaining glutamatergic synaptic transmission.
RESULTS
To assist in defining the cellular expression of GS, we immunostained brain sections from young adult (P60-75) Aldh1L1-EGFP mice, in which all astrocytes express EGFP (Zhang et al., 2014) . Consistent with previous reports of astrocyte GS expression, there were numerous EGFP+ GS+ cells ( Figure 1A , yellow arrows). However, we also observed an abundant population of GS+ EGFPÀ cells ( Figure 1A , blue arrowheads; Figure 1E ) in subcortical regions of the brain. Immunohistochemistry with aspartoacylase (ASPA), which is selectively expressed by mature oligodendrocytes (Larson et al., 2018) , indicated that these GS+ EGFPÀ cells were oligodendrocytes ( Figure 1B ). Immunostaining in MOBP-EGFP mice, in which mature oligodendrocytes express EGFP (Larson et al., 2018) , also revealed widespread colocalization between EGFP+ oligodendrocytes and GS ( Figures 1C and 1F) . GS immunoreactivity was absent from cells expressing NeuN (neurons), CX3CR1 GFP (microglia), or PDGFRa (oligodendrocyte progenitors) ( Figure 1F ; Figures S1AÀS1C). As an additional means of comparing astrocyte and oligodendrocyte levels of GS protein, we used fluorescence-activated cell sorting (FACS) to isolate oligodendrocytes or astrocytes from the midbrain of MOBP-EGFP and Aldh1L1-EGFP mice ( Figure S1G ), respectively, and quantified GS protein by western blot. Again, we detected GS expression in both astrocytes and oligodendrocytes ( Figure 1G ).
To corroborate these findings at the mRNA level, we performed in situ hybridization for Glul, the gene that encodes GS. Consistent with immunostaining analysis, Glul probe colocalized with the astrocyte-specific transcript Slc1a2 and the oligodendrocyte-specific transcript Mobp in wild-type mice (Figures 1D  and 1H ; Figure S1E ), as well as Egfp transcript in MOBP-EGFP mice ( Figure S1d ). Given previous reports of GS mRNA expression in microglia and oligodendrocyte progenitors (Nakajima et al., 2017; Palmieri et al., 2017; Zhang et al., 2014) , we also probed for Aif1 (Iba1, expressed in microglia) and Pdgfra (expressed in oligodendrocyte progenitors); neither transcript colocalized with Glul ( Figure S1F ). Consistent with the western blot data, qPCR analysis of Glul mRNA from FACS-isolated oligodendrocytes or astrocytes (Figures S1G and S1H) detected abundant Glul expression in both cell types ( Figure 1I ). Collectively, these results indicate that oligodendrocytes express both GS mRNA and protein.
Given the widespread reports of GS expression being exclusive to astrocytes, we hypothesized that GS expression in oligodendrocytes may be temporally restricted. Indeed, analysis of GS expression in wild-type animals at several developmental time points revealed that oligodendrocyte GS expression only emerged at P21 and continued to increase in subsequent weeks (Figures 2A and 2C ). In addition, GS intensity was much higher in oligodendrocytes in caudal regions, such as the ventral midbrain and spinal cord, than in rostral regions like the cortex and hippocampus ( Figures 2B, 2D , and 2E; Figure S2A ). This pattern held true for both the percentage of GS-expressing oligodendrocytes ( Figure 2D ; F = 43.02, p < 0.0001) and the fluorescence intensity of GS in oligodendrocytes relative to overall GS intensity in the section ( Figure 2E ; Kruskal-Wallis test, p < 0.0001). Western blot of GS in oligodendrocytes isolated from the cortex or midbrain also revealed a significant difference in regional GS expression ( Figure 2F ; t = 5.051, p = 0.0072). A similar pattern emerged when we quantified Glul mRNA ( Figures S2B and  S2D ). This regional heterogeneity in oligodendrocyte GS expression was partially maintained when we cultured oligodendrocyte progenitors from the midbrain or cortex and differentiated them into oligodendrocytes in vitro (Figures S2C and S2E) , suggesting some degree of cell-intrinsic GS regulation. The late onset and regional heterogeneity of oligodendrocyte GS expression may in part explain why GS has thus far been predominantly associated with astrocytes.
To determine the functional significance of oligodendrocyte GS expression, we generated oligodendrocyte-specific GS knockout mice by crossing MOG-iCre mice (Hö velmeyer et al., 2005) with floxed GS mice (He et al., 2010 GS t = 1.073, p = 0.3004). To examine the effect of this reduction on tissue glutamate homeostasis, we measured GS substrates in midbrain tissue using colorimetric assays. We detected reductions in glutamate and glutamine in cKO animals ( Figure 3E ; glutamate paired t = 2.852, p = 0.0463; glutamine paired t = 5.037, p = 0.004), but no differences in tissue levels of ammonia and/or ammonium ( Figure 3E ; paired t = 2.075, p = 0.0927), glutathione ( Figure S3C ; paired t = 1.684, p = 0.1908), or NADH ( Figure S3C ; paired t = 0.8253, p = 0.4697), which also incorporate glutamate in their synthetic pathways. Thus, removal of oligodendrocyte GS selectively impacts tissue levels of glutamate and glutamine. To determine whether oligodendrocyte GS deletion impairs myelination, we measured myelin protein levels by western blot and immunostained for MBP in control and cKO animals. We detected no differences in myelin protein levels ( Figure 3G Figure 3F ; Figure S3D ) between the two groups. To evaluate myelin integrity at the ultrastructural level, we performed EM analysis of myelinated axons in the spinal cord ( Figure 3H ; Figure S3F ), a white matter tract that exhibited high oligodendrocyte GS expression in wild-type animals (Figures 2D and 2E ; Figure S2A ). We observed no differences in axon diameter or area (Figures 3I and 3K;  Figure S3G ; axon diameter t = 0.1311, p = 0.902; axon area t = 0.3318, p = 0.7567), myelin thickness ( Figure 3K ; t = 0.7996, p = 0.4688), g-ratio (Figures 3J and 3K ; Welch-corrected t = 1.738, p = 0.2225), or the relationship between g-ratio and axon diameter ( Figure 3J ; Figure S3G ; slope of best-fit lines, t = 1.011, p = 0.3691), indicating that oligodendrocyte GS expression is not required for myelination.
To determine whether oligodendrocyte GS deletion disrupts neuronal glutamate transmission, we performed slice whole cell patch clamp recordings from dopamine neurons in the ventral midbrain, where we had observed high GS expression in wild-type ( Figure 2B ) and control ( Figure 3A) animals. Oligodendrocyte GS deletion did not affect the spontaneous firing rate (t = 1.129, p = 0.264), membrane resistance (t = 0.1098, p = 0.9133), and cell capacitance (t = 0.3577, p = 0.7229) of dopamine neurons (Figures S4AÀS4E), indicating no gross differences in neuronal health. However, the amplitude of miniature excitatory post-synaptic currents (mEPSCs) was significantly reduced in cKO animals (Figures 4A and 4C;  Figure S4F ; t = 2.682, p = 0.0158), without significant changes in mEPSC frequency ( Figure 4B ; Figure S4F ; t = 1.605, p = 0.1269), rise time ( Figure S4G ; t = 0.09417, p = 0.9261), or decay tau ( Figure S4H ; t = 0.8004, p = 0.4345). Furthermore, when we electrically evoked synaptic glutamate release, we observed a significant reduction in the amplitude of evoked EPSCs (eEPSCs) measured from cKO animals across a range of stimulating intensities (Figure 4D ; F = 4.705, p = 0.0359). To clarify whether this deficit is due to a requirement for ongoing GS activity or, perhaps, a manifestation of earlier deficits that occurred during development, we acutely inhibited GS in control slices using the pharmacological GS inhibitor L-methionine sulfoximine (MSO). Pre-incubation with MSO (5 mM) led to a significant reduction in eEPSC amplitude, recapitulating the deficit we detected in cKOs ( Figure 4E ; F = 4.351, p = 0.0193). This reduction could be prevented by pre-incubation with both MSO and exogenous glutamine (Gln; 500 mM) ( Figure 4E ). Although we cannot distinguish the relative contribution of oligodendrocyte GS and astrocyte GS activity in these pharmacological experiments, the fact that acutely inhibiting GS produces a similar deficit as seen in our cKO animals suggests that ongoing production of glutamine by oligodendrocyte GS is required for proper glutamatergic transmission in the midbrain. In line with this interpretation, pre-incubation with glutamine significantly increased the eEPSC amplitude in cKO slices but not in control slices ( Figure 4F ; control slices F = 3.18, p = 0.0905; cKO slices F = 4.964, p = 0.0406), suggesting that a decrease in glutamine production underlies the deficits observed in cKO animals.
Changes in glutamate signaling in the ventral midbrain are associated with the acquisition of certain psychoactive drugrelated behaviors (Mahler et al., 2013; Mao et al., 2011; Ungless et al., 2001; Wang et al., 2012) . In particular, cocaine-induced locomotor sensitization (i.e., a progressive escalation of locomotor activity in response to repeated cocaine exposure) requires elevations in midbrain glutamate (Kalivas and Duffy, 1998) . Therefore, we investigated whether the deficits in midbrain glutamatergic transmission we detected in cKO animals would affect their behavioral response to repeated injections of cocaine. Animals were placed in open field boxes outfitted with infrared beams to measure locomotor activity. Following 1 h of baseline activity, animals received an intraperitoneal injection of saline (days 1 and 2, for habituation; Figure S4I ) or 10 mg/kg cocaine (days 3À7). By day 7, both control and cKO animals displayed a large cocaine-induced increase in locomotor activity (Figure S4I) . Quantification of distance traveled in the hour prior to drug injection revealed no significant differences in baseline activity between groups ( Figure 4G ; F = 2.784, p = 0.1147). However, cKO animals moved significantly less than control animals in the hour following cocaine injection ( Figure 4H ; F = 7.775, p = 0.0132). Thus, oligodendrocyte GS deletion significantly impacts performance in a midbrain-dependent behavior.
DISCUSSION
In the present study, we report an unexpected myelin-independent role for oligodendrocytes in supporting glutamatergic transmission. This aspect of oligodendrocyte function is mediated by expression of the glutamate-metabolizing enzyme GS. Oligodendrocyte GS expression appears late in development and is regionally heterogeneous, with higher expression in more caudal regions of the CNS. Selective deletion of oligodendrocyte GS disrupted midbrain glutamatergic synaptic transmission and cocaine-induced locomotor sensitization, a behavior that requires glutamate signaling in the midbrain. These results represent a significant departure from the canonical view of glutamate metabolism in the CNS (Jayakumar and Norenberg, 2016; Rose et al., 2013) , which posits that glutamate and glutamine are exchanged solely between astrocytes and neurons.
Our data also revealed an unexpected dimension of regional oligodendrocyte heterogeneity. The differences in oligodendrocyte GS expression across the CNS may reflect different regional needs for glutamate processing but may also be due to differences in cell-intrinsic metabolic demands. In addition to metabolizing glutamate and synthesizing glutamine, GS also metabolizes ammonia, which can be a toxic byproduct of amino acid biosynthesis (Rose et al., 2013) . Although the present study focused on the impact of oligodendrocyte GS deletion on (E) Quantification of GS metabolites in microdissected midbrains via colorimetric assays. One control and one cKO animal were processed in parallel per day; control and cKO values from the same day were paired for analysis. Glutamate paired t = 2.852, df = 4, p = 0.0463, n = 5 animals per group. Glutamine paired t = 5.037, df = 5, p = 0.004, n = 6 animals per group. NH3/NH4+ paired t = 2.075, df = 5, p = 0.0927, n = 6 animals per group. neuronal glutamate transmission, GS may play other cellautonomous roles in oligodendrocytes related to ammonia processing. Further investigation of mechanisms regulating GS expression in oligodendrocytes, as well as potential roles of GS in cell-autonomous oligodendrocyte processes, may yield important insights into regional oligodendrocyte specialization and function. Although GS is widely considered to be astrocyte-specific (Armbruster et al., 2016; Habbas et al., 2015; Okuda et al., 2014; Papageorgiou et al., 2018; Theofilas et al., 2017; Tong et al., 2014) , there have been reports of GS expression, particularly at the mRNA level, in oligodendrocyte progenitors and microglia (Nakajima et al., 2017; Palmieri et al., 2017; Zhang et al., 2014) . Within the ventral midbrain of naive young adult mice, we did not detect expression of GS mRNA or protein in these cell types. However, it is possible that they express GS in other brain regions or upregulate GS expression in aging or pathological contexts (Nakajima et al., 2017; Palmieri et al., 2017) , especially given the sensitivity of oligodendrocyte progenitors and microglia to injury and disease (Hickman et al., 2018; Hughes et al., 2013) .
The differential effects of glutamine pre-incubation on control and cKO slices suggest that the deficit in glutamatergic signaling we observed in cKO animals is at least partially due to decreased glutamine availability. However, it is unclear whether glutamine pre-incubation was able to increase EPSC amplitude in cKO slices by directly replenishing the presynaptic glutamine pool used for glutamate synthesis. It is also possible that glutamine indirectly enhances transmission efficacy by acting as an energy substrate for axons (Amaral, 2013) . In either case, these data indicate an ongoing requirement for oligodendrocyte GS activity in supporting glutamate transmission, at least in a brain region where GS is robustly expressed by oligodendrocytes.
How might oligodendrocytes exchange GS substrates with neurons? Some studies have indicated that oligodendrocytes express transporters that are permissible to glutamate and glutamine, such as EAAC1 (DeSilva et al., 2009 ), SNAT3 (Marques et al., 2018 , and ASCT2 (Scopelliti et al., 2018) , which would allow for a direct exchange of GS substrates with axons. Furthermore, we previously reported extensive gap junction coupling between midbrain oligodendrocytes and astrocytes (Xin et al., 2019) . As molecules smaller than 1 kDa can theoretically pass freely through gap junctions (Berg et al., 2002) , these structural connections may enable exchange of GS substrates between astrocytes and oligodendrocytes and thus neurons by way of astrocyte transporters. Intriguingly, the temporal expression pattern of the astrocyte connexin 30 (CX30) closely parallels that of oligodendrocyte GS, with expression onset around 2 weeks postnatally (Kunzelmann et al., 1999; Nagy et al., 1999) . Spatially, there is also correspondence between CX30 expression and oligodendrocyte GS expression; both are enriched in hindbrain regions and low in white matter tracts (Griemsmann et al., 2015; Nagy et al., 1999) . Whether glutamate and glutamine exchange occur directly via oligodendrocyte transporters or via astrocyte intermediaries will require additional functional studies, ideally combined with cell-type specific deletion of connexins or transporters. Elucidating the downstream mechanisms that enable oligodendrocyte-neuron interactions in the context of glutamate and glutamine shuttling will be important for furthering our understanding of glutamate processing in the brain.
Finally, these results point to oligodendrocytes as potential players, and perhaps even therapeutic targets, in the numerous CNS pathologies involving glutamate dysregulation (Jayakumar and Norenberg, 2016; Sheldon and Robinson, 2007) . Indeed, there is evidence that impaired oligodendrocyte function and/ or myelination is accompanied by changes in brain glutamate levels (Gao et al., 2018; Maheras et al., 2018; Nantes et al., 2017; Takanashi et al., 2014; Werner et al., 2001) . Moving forward, studies on the role of glutamate in various pathological states should consider the possibility of dual roles for oligodendrocytes as victim and perpetrator of glutamate-related CNS dysfunction.
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STAR+METHODS KEY RESOURCES TABLE CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Antonello Bonci (antonello.bonci@nih.gov).
EXPERIMENTAL MODEL AND SUBJECT DETAILS Mice
Unless indicated, both male and female mice were used, and the number of males and females in each analysis group was balanced. No significant effect of sex was observed in data analyses. Ages of mice used in each experiment are described in the Method Details REAGENT section below. Mice were housed in normal light dark (lights on 7am, lights off 7pm) cycle and had ad libitum access to food and water. Mice were group housed 2-5 to a cage and had no prior history of drug administration, surgery, or behavioral testing. All experiments were performed in strict accordance with protocols approved by the Animal Care and Use Committee at NIDA. Wild-type mice (C57BL/6J; JAX 000664) were purchased from Jackson Laboratories. Aldh1L1-eGFP mice (OFC789Gsat/ 011015-UCD) were purchased from MMRRC and maintained as heterozygotes by crossing with FVB mice. MOBP-eGFP mice (IN1Gsat) were originally obtained from MMRRC and maintained as homozygotes. CX3CR1-eGFP mice were originally obtained from Jackson Labs (JAX 005582) and maintained as homozygotes. MOG-iCre mice were generated by Dr. Ari Waisman (Hö velmeyer et al., 2005) . GS fl/fl mice were generated by Dr. Wouter Lamers (He et al., 2010) . For experiments using MOG-iCre x GS fl/fl mice, GS fl/fl mice were bred with MOG-iCre +/À GS fl/fl mice to obtain a mix of MOG-iCre -GS fl/fl (''control'') and MOG-iCre + GS fl/fl (''cKO'') pups.
Primary cell culture Pregnant CD1 mice were ordered from Jackson labs and housed in normal light dark cycle with ad libitum access to food and water. P5-P7 pups were used to make primary oligodendrocyte progenitor cell cultures.
METHOD DETAILS Immunohistochemistry
Mice aged postnatal day 14 (''P14''), 21 (''P21''), 28-29 (''P28''), 58-69 (''adult''), or 87-90 (''P90'') were deeply anesthetized with Euthasol (sodium pentobarbital 150 mg/kg and sodium phenytoin 19.2mg/kg, Virbac) and perfused transcardially with 4% paraformaldehyde in 1X PBS. Brain tissue was isolated and postfixed in this solution for 4 hr at 4 C, then stored in 1X PBS with 0.1% NaAz. Coronal brain sections (50 mm) were prepared on a vibratome in chilled 1X PBS. For quantification of GS intensity in different brain regions, brains were sucrose protected (30% in PBS) prior to flash freezing and sectioned on a cryostat (20 mm). Free-floating sections (both vibratome and cryostat sectioned) were permeabilized/blocked with 0.2% Triton X-100 and 5% normal donkey serum in 1X PBS for 1hr at room temperature. Sections were incubated with primary antibodies prepared in 0.2% Triton X-100 and 5% normal donkey serum in 1X PBS at 4 C overnight. Sections were incubated with secondary antibodies in 5% normal donkey serum in 1X PBS for 2hr at room temperature. Primary antibodies and concentrations used are listed in the Key Resources Table. Primary antibodies have been validated for use in immunohistochemistry in mouse tissue, in published literature, and on the manufacturer's websites. Secondary antibodies used included the following: Alexa Fluor 488-, 594-, or 647-conjugated secondary antibodies to rabbit, mouse, goat, chicken, rat or guinea pig (1:500; all raised in donkey; Jackson ImmunoResearch). No sex differences were observed (e.g., GS fluorescence in midbrain, K-S D = 0.0553, p = 0.8944).
Image acquisition and analysis
For all experiments, confocal fluorescence images were acquired with an Olympus FV1000 microscope. For quantification of GS+ cell density and GS intensity, stacks of confocal images were acquired using a 20X objective and a 1.5 mm z-interval and analysis was performed on maximum projections of confocal stacks within ImageJ software. For quantification of GS intensity in slice, regions of interest (ROIs) were manually delineated in ImageJ based on MOBP-eGFP or ASPA immunoreactivity using the freehand tool, and mean intensity for individual ROIs was extracted; similar patterns were observed when using integrated density in the place of mean intensity. For all imaging analyses, at least 2 images from separate brain sections were analyzed per mouse to obtain a summed value for that mouse.
Tissue dissociation and flow cytometry MOBP-eGFP or Aldh1L1-eGFP mice, aged 2-3mo, were deeply anesthetized with Euthasol and perfused transcardially with sodiumsubstituted artificial cerebral spinal fluid (NMDG ACSF) containing, in mM, 92 NMDG, 20 HEPES, 25 glucose, 30 NaHCO3, 1.2 NaH2PO4, 2.5 KCl, 5 sodium ascorbate, 3 sodium pyruvate, 2 thiourea, 10 MgSO4, and 0.5 CaCl2 (pH7.35, $300 mOsm, saturated with 95%O2/5% CO2). Brains were rapidly extracted; cortex and midbrain were microdissected on ice. Microdissected regions were minced and transferred to microtubes containing ice-cold Hank's Buffered Salt Solution (no Ca 2+ /Mg2+). Tissue was dissociated into a single cell suspension using the Miltenyi Neural Tissue Dissociation Kit (version 'P'). Briefly, tissue was enzymatically digested for 30min at 37 C and manually triturated using fire-polished glass Pasteur pipets with progressively smaller diameter openings (final pipet $0.4mm diameter) (Rubio et al., 2016) . Cell suspensions were pelleted and resuspended in PBS for sorting via flow cytometry.
Samples were sorted using a BD Biosciences FACS Aria I cell sorter into either 200mL of extraction buffer from the Arcturus PicoPure RNA isolation kit for qPCR, or 50mL PBS for western blot. Cell suspensions from wild-type tissue were used to establish eGFP-negative gates. Oligodendrocytes and astrocytes were identified based on forward scatter (FSC), side scatter (SSC), and FITC channel intensity (see Figure S1G ). Samples from individual animals were not pooled. Using tissue microdissected from individual animals, we collected an average of 53052 ± 15841 cortical oligodendrocytes, 52318 ± 18446 midbrain oligodendrocytes, 48461 ± 20432 cortical astrocytes, and 67385 ± 4511 midbrain astrocytes (per animal). For each sample, 70000 eGFP-cells were also collected for validation of cell-type specific qPCR primers and probes.
RNA isolation
RNA from sorted cells was isolated using the PicoPure RNA isolation kit (Arcturus Bioscience). Cells were sorted into Eppendorf tubes containing 200 mL PicoPure RNA extraction buffer and, following the sort, samples were incubated at 42 C for 30 min, and stored in RNase-free tubes at À80 C until further processing. Column filtration, washing, and elution of RNA from the columns was performed according to manufacturer's instructions in section IV.C of the PicoPure RNA Isolation Kit User Guide.
cDNA synthesis and RT-PCR analysis of gene expression Single strand cDNAs were synthesized with Superscript III first strand cDNA synthesis kit (Invitrogen, Life Technologies), according to the manufacturer's protocol. Duplex RT-PCR assays were performed on technical duplicates using a FAM-labeled probe for each target gene, and a VIC-labeled probe for the endogenous control gene (Gapdh), along with TaqMan Advanced Fast PCR Master Mix (Cat# 4444963; Life Technologies). To avoid amplification of genomic DNA contamination, primers and probes that amplify across target gene exon-exon junctions were selected when possible. RT-PCR reactions were run in a 7500 Fast TaqMan instrument using the program: 95 C hold for 20 s, followed by 40 cycles of 95 C denaturation for 3 s, and 60 C annealing and extension for 30 s. Calculations of relative expression from Ct data were carried out according to User Bulletin #2 for ABI Prism 7900 Sequence Detection System. For each target gene, the average Ct value for the endogenous control (Gapdh) was subtracted from the average Ct value for the target gene, to obtain DCt. The relative expression was then plotted as 2-DCt. All TaqMan assays and custom primers/probes that were used are detailed in the Key Resources Table. No sex differences were observed (e.g., Midbrain Glul in oligodendrocytes, t = 0.5093, p = 0.6457).
In situ hybridization using RNAscope Aldh1L1-eGFP and MOBP-eGFP mice aged P60-P65 were deeply anesthetized with an intraperitoneal injection of Euthasol. Animals irresponsive to toe pinches were decapitated, and brains were rapidly extracted and flash frozen in isopentane. Brains were directly collected onto SuperFrost microscope slides at 14mm using a cryostat. Sections were dehydrated with ethanol and incubated with RNAscope probes according to the manufacturer's instructions for the RNAscopeâ Multiplex Fluorescent Assay. Sections were imaged as a Z stack on the confocal microscope described above at a 1 mm z-interval. No sex differences were observed in the RNAscope dataset (e.g., % Glul+ oligodendrocytes, t = 0.4029, p = 0.726).
Cell culture
For cell culture experiments, CD1 P5-P7 pups were used, with 3-5 animals per experimental group. Pups were not sexed prior to sacrifice. Pups were rapidly decapitated and brain tissue was immediately placed in ice-cold HBSS with no Ca 2+ and Mg2+
(ThermoFisher Scientific, #14175103). Cortices were resected from the rest of the brain, and motor and frontal cortices were dissected with additional care taken to avoid including any calossal white matter. Midbrain tissue was dissected by another investigator at the same time. Afterward, midbrain and cortical tissue was then processed in parallel using Neural Tissue Dissociation kit according to the manufacturer's instructions (#130-092-628). OPC purification was performed using anti-O4 isolation beads (#130-094-543), MS columns (#130-042-201), and a MiniMACs Separator (130-042-102), according to the manufacturer's instructions (all Miltenyi Biotec). Cells were spotted at the density 12-15 thousand cells/well on Poly-D-lysine (Milipore-Sigma, # P6407, 10 mg/ml) coated glass coverslips (Warner Instruments, #64-0702) in 50-80 mL of OPC culture medium and allowed to adhere for 20 minutes in a tissue culture incubator maintained at 37 C and 5% CO2. Afterward, the wells were gently flooded with the culture medium up to the total volume of 250-300 ml. OPC culture medium consisted of the following: DMEM:F12 (ThermoFisher Scientific, #11330032), N2B (Stem Cell Technologies, 1:1000 stock, #7156), SM1 (Stem Cell Technologies, 1:50, #5711), Penicillin/Streptomycin (ThermoFisher Scientific, 1:200 stock), N-Acetyl-Cysteine (Sigma-Milipore, #A8199, 5 mg/ml), forskolin (Calbiochem, #344270, 5uM), CNTF (Peprotech, #450-50, 10ng/ml), PDGF-AA (Peprotech, #100-13A, 20ng/ml), NT-3 (#450-03B, 1ng/ml). To induce OPC differentiation, the day after cell plating OPC culture medium was replaced with the medium no longer containing PDGF-AA and NT3, but supplemented with T3 (Milipore-Sigma, #T6397, 4ng/ml). Cells were then cultured for 4-6 additional days to ensure uniform differentiation. Cells were fixed with 4% PFA for 12-15 minutes, washed 3x5min with PBS and processed for staining. Data were collected from three separate cohorts.
Western blotting
For tissue western blots, control and cKO mice aged P90-P105 were deeply anesthetized with an intraperitoneal injection of Euthasol. Animals irresponsive to toe pinches were decapitated, and midbrains were dissected out on ice, then flash frozen in isopentane. Tissues were homogenized in RIPA lysis buffer (Cell Signaling Technology) and protein concentration for each sample was quantified with a Bio-Rad Protein Assay. A total of 30 mg of proteins per sample was loaded for each run.
For FACS-isolated cells, samples were diluted with PBS down to the same number of cells across groups. Laemmli buffer with 2-mercaptoethanol were added to samples (1 part Laemmli to 3 parts sample volume). Mixtures were boiled on a preheated hot plate for 5 minutes at 95 C. 20 mL per sample were loaded for each run. Membranes were blocked overnight with Li-Cor Blocking Buffer at 4C, then incubated with primary antibodies diluted in the same buffer for 2 hours at RT, washed, then incubated with secondary antibodies for 1.5 hours at RT. Antibodies used are listed in the Key Resources Table. Membranes were scanned using a LI-COR Odyssey Image System. Band intensities were measured using ImageJ
Electron Microscopy
Control and cKO mice aged P73-P78 were perfused with 60mL (5.5mL/min) 4% paraformaldehyde (freshly prepared from EM grade prill form paraformaldehyde), 2% glutaraldehyde, 3mM MgCl2, in 0.1M sodium cacodylate buffer, pH7.2. After perfusion, spinal cords were dissected out and placed in fresh fixative overnight at 4 C. After buffer rinse, samples were postfixed in reduced 2% osmium tetroxide, 1.6% potassium ferrocyanide in buffer (2 hr) on ice in the dark. Following a dH2O rinse, samples were stained with 2% aqueous uranyl acetate (0.22mm filtered, 1 hr, dark), dehydrated in a graded series of ethanol, propylene oxide and embedded in Eponate 12 (Ted Pella) resin. Samples were polymerized at 60 C overnight. Thin sections, 60-90nm, were cut with a diamond knife on the Reichert-Jung Ultracut E ultramicrotome and picked up with copper slot (1 3 2 mm) grids. Grids were stained with 2% uranyl acetate and observed with a Philips/FEI BioTwin CM120 TEM at 80kV. Images were captured with an AMT CCD (1K x 1K) camera.
For analysis, axons were traced in Fiji ImageJ (Schindelin et al., 2012) using the freehand tool. A minimum of 200 axons per animal were traced. Inner and outer axon diameters represent feret diameters calculated by ImageJ. G-ratio was defined as inner feret diameter divided by outer feret diameter. Myelin thickness was defined as the outer feret diameter minus the inner feret diameter, divided by two. No sex differences were observed (e.g., g-ratio t = 1.19, p = 0.300).
QUANTIFICATION AND STATISTICAL ANALYSIS
All graphed values are shown as mean ± SEM. Statistical details of experiments (statistical tests used, statistical values, exact n, what n represents) can be found in the figure legends, and abbreviated statistics are also included in the results section. The number of animals included in each experiment was based on standards established in the literature and not predetermined by statistical methods. Data were entered in Microsoft Excel; statistics were performed using GraphPad Prism 8. Statistical significance was defined as having a p value of less than 0.05. Tests for normality and equal variances were used to determine the appropriate statistical test to employ. For datasets that did not pass the normality test in Prism, non-parametric tests (Kolmogorov-Smirnov test for two groups, Kruskal-Wallis test for more than two groups) were used. All reported t tests were two-tailed, with Welch's correction when group variances were significantly different. For colorimetric experiments, paired t tests were used; for all other experiments, unpaired t tests were used. For experiments with more than two groups, one-way ANOVAs were used. For experiments with more than one variable, two-way ANOVAs were used. For experiments with repeated-measurements from the same animals, two-way repeated-measures ANOVAs were used. Welch-corrected ANOVA tests were used when group variances were significantly different. Linear regression was used to test dependence of g-ratio on axon diameter.
